These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33644840)

  • 1. Selective extraction of low-abundance BRAF V600E mutation from plasma, urine, and sputum using ion-tagged oligonucleotides and magnetic ionic liquids.
    Emaus MN; Anderson JL
    Anal Bioanal Chem; 2022 Jan; 414(1):277-286. PubMed ID: 33644840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence-specific preconcentration of a mutation prone KRAS fragment from plasma using ion-tagged oligonucleotides coupled to qPCR compatible magnetic ionic liquid solvents.
    Emaus MN; Varona M; Anderson JL
    Anal Chim Acta; 2019 Aug; 1068():1-10. PubMed ID: 31072469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective hybridization and capture of KRAS DNA from plasma and blood using ion-tagged oligonucleotide probes coupled to magnetic ionic liquids.
    Emaus MN; Zhu C; Anderson JL
    Anal Chim Acta; 2020 Jan; 1094():1-10. PubMed ID: 31761034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximizing Ion-Tagged Oligonucleotide Loading on Magnetic Ionic Liquid Supports for the Sequence-Specific Extraction of Nucleic Acids.
    Clark KD; Zhu C; Anderson JL
    Anal Chem; 2019 May; 91(9):5945-5952. PubMed ID: 30995833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic discrimination between circulating tumor DNA fragments enabled by a multiplex-qPCR assay containing DNA-enriched magnetic ionic liquids.
    Emaus MN; Anderson JL
    Anal Chim Acta; 2020 Aug; 1124():184-193. PubMed ID: 32534671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of the BRAF
    Ashida A; Sakaizawa K; Mikoshiba A; Uhara H; Okuyama R
    Int J Clin Oncol; 2016 Oct; 21(5):981-988. PubMed ID: 27041702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease.
    Janku F; Vibat CR; Kosco K; Holley VR; Cabrilo G; Meric-Bernstam F; Stepanek VM; Lin PP; Leppin L; Hassaine L; Poole JC; Kurzrock R; Erlander MG
    Oncotarget; 2014 Jun; 5(11):3607-10. PubMed ID: 25003820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic ionic liquids as microRNA extraction solvents and additives for the exponential amplification reaction.
    Emaus MN; Anderson JL
    Anal Chim Acta; 2021 Oct; 1181():338900. PubMed ID: 34556230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arabidopsis thaliana ITS sequence-specific DNA extraction by ion-tagged oligonucleotides coupled with a magnetic ionic liquid.
    Marengo A; Emaus MN; Bertea CM; Bicchi C; Rubiolo P; Cagliero C; Anderson JL
    Anal Bioanal Chem; 2019 Oct; 411(25):6583-6590. PubMed ID: 31422433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. It was not possible to detect BRAF V600E mutation in circulating cell-free DNA from patients with ameloblastoma: A diagnostic accuracy study.
    Martins-de-Barros AV; da Costa Araújo FA; Barros AMI; Dos Santos EGF; Barbosa Neto AG; da Silva HAM; de Lima ELS; Muniz MTC; Neves RFSN; de Hollanda Valente RO; de Oliveira E Silva ED; de Vasconcelos Carvalho M
    J Oral Pathol Med; 2024 Apr; 53(4):258-265. PubMed ID: 38494749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients.
    Tzanikou E; Haselmann V; Markou A; Duda A; Utikal J; Neumaier M; Lianidou ES
    Clin Chem Lab Med; 2020 Oct; 58(11):1799-1807. PubMed ID: 31953992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity PCR method for detecting BRAF V600E mutations in metastatic colorectal cancer using LNA/DNA chimeras to block wild-type alleles.
    Chen D; Huang JF; Xia H; Duan GJ; Chuai ZR; Yang Z; Fu WL; Huang Q
    Anal Bioanal Chem; 2014 Apr; 406(9-10):2477-87. PubMed ID: 24500755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma.
    Lubitz CC; Parangi S; Holm TM; Bernasconi MJ; Schalck AP; Suh H; Economopoulos KP; Gunda V; Donovan SE; Sadow PM; Wirth LJ; Sullivan RJ; Panka DJ
    J Mol Diagn; 2016 Jan; 18(1):100-8. PubMed ID: 26631873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating BRAF
    Lubitz CC; Zhan T; Gunda V; Amin S; Gigliotti BJ; Fingeret AL; Holm TM; Wachtel H; Sadow PM; Wirth LJ; Sullivan RJ; Panka DJ; Parangi S
    Thyroid; 2018 Mar; 28(3):328-339. PubMed ID: 29378474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF(V600E) mutation analysis from May-Grünwald Giemsa-stained cytological samples as an adjunct in identification of high-risk papillary thyroid carcinoma.
    Patel A; Klubo-Gwiezdzinska J; Hoperia V; Larin A; Jensen K; Bauer A; Vasko V
    Endocr Pathol; 2011 Dec; 22(4):195-9. PubMed ID: 21948220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR.
    Reid AL; Freeman JB; Millward M; Ziman M; Gray ES
    Clin Biochem; 2015 Oct; 48(15):999-1002. PubMed ID: 25523300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.
    Bösmüller H; Fischer A; Pham DL; Fehm T; Capper D; von Deimling A; Bonzheim I; Staebler A; Fend F
    Hum Pathol; 2013 Mar; 44(3):329-35. PubMed ID: 23089489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the BRAF V600E Mutation in Colorectal Cancer by NIR Spectroscopy in Conjunction with Counter Propagation Artificial Neural Network.
    Zhang X; Yang Y; Wang Y; Fan Q
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31208050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the follow-up of patients with melanoma being treated with BRAF inhibitors.
    Sanmamed MF; Fernández-Landázuri S; Rodríguez C; Zárate R; Lozano MD; Zubiri L; Perez-Gracia JL; Martín-Algarra S; González A
    Clin Chem; 2015 Jan; 61(1):297-304. PubMed ID: 25411185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of BRAF
    Pierry C; Caumont C; Blanchard E; Brochet C; Dournes G; Gros A; Bandres T; Verdon S; Marty M; Bégueret H; Merlio JP
    Virchows Arch; 2018 Feb; 472(2):247-258. PubMed ID: 28711990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.